Latest Juvenile myelomonocytic leukemia Stories

2008-10-06 12:00:42

A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted. "We've eliminated a...

2008-09-17 09:00:14

DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced today the formation of a European Medical Advisory Board (MAB) to provide medical/clinical strategic guidance to the Company as it relates to the ongoing development of orBec(R) for the treatment of gastrointestinal...

2008-06-19 15:00:08

U.S. scientists have discovered genetic mutations that make cells cancerous can sometimes make them more sensitive to chemotherapy. Specifically, an Ohio State University study shows a mutation in some cases of acute leukemia makes the disease more susceptible to high doses of a particular anticancer drug. The researchers, led by Dr. Clara Bloomfield, said their finding could change the manner by which physicians manage such patients. The retrospective study shows people with acute...

2008-03-26 03:00:08

By Rodriguez, Fausto J Perry, Arie; Gutmann, David H; O'Neill, Brian Patrick; Leonard, Jeffrey; Bryant, Sandra; Giannini, Caterina Abstract There are few pathologic studies of gliomas in patients with neurofibromatosis type 1. We analyzed clinical and pathologic features of gliomas from 100 neurofibromatosis type 1 patients (57 men; 43 women). The median age at tumor diagnosis was 13 years (range, 4 months to 68 years). Most tumors were typical pilocytic astrocytoma (PA) (49%) or diffusely...

2006-02-17 00:30:00

By Joanne Morrison WASHINGTON (Reuters) - Researchers can predict which bone marrow transplant patients will likely develop a deadly complication a week after the procedure and well before any symptoms occur, according to a study released on Friday. Researchers at the University of Michigan Comprehensive Cancer Center found that elevated levels of a protein called tumor necrosis factor, or TNF, measured a week after patients received bone marrow transplants, were found among those who later...

Word of the Day
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'